Patient P-02220
Synthetic patientMETA-24 · Day 175 · 25–34 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Improving
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
27%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S14
- Day 30 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 30.
Primary contributors, last 14 days
- Nutritional resilience+13
- Toxicity-11
- Inflammatory activity-8
- Treatment adherence+8
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable21 min
improving · +1.4 vs previous 14 d
Sleep duration
Wearable7.3 h
stable · +0.0 vs previous 14 d
Energy level
Daily log6.4/10
improving · +0.5 vs previous 14 d
Steps
Wearable3,240
improving · +465 vs previous 14 d
GI burden
Companion22.3/100
improving · -2.7 vs previous 14 d
Adherence
Companion87 %
stable · +2.7 vs previous 14 d
Sleep quality
Wearable44.5/100
stable · +1.5 vs previous 14 d
Glucose, CGM daily mean
CGM136 mg/dL
stable · +0.1 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 69 from the failing basin, 26 from restoration.
Good elements to keep
- Protein (supports)perturbation · steering +11.4
- Butyrate producers intacthidden · steering +7.5
- Proteinsupporter · GI -6 next day
Main detractors to watch
- Rapid metabolizerhidden · steering -8
- Alcohol on dosing daysperturbation · steering -1.8
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-6supporter · 95%
- Dietary fat load+1.3no signal · 30%
- Caffeine+1.1no signal · 21%
- Ultra-processed food-0.9no signal · 18%
- Insoluble fibre+0.7no signal · 15%
- Alcohol+0.7no signal · 15%
- Simple carbohydrates+0.4no signal · 15%
- Histamine load-0.3no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Autonomic recovery ↓20
- Wearable3,240 steps/day
- Inflammatory signalling ↓15
- WearableHRV 27 ms, trending down
DNA
Fictional pharmacogenomic panel
- CYP2D6 Rapid metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 4.2 · butyrate capacity 78/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 32 ms
- Sleep
- 7.2 h
- Steps
- 4,226
- Resting HR
- 60 bpm
Daily log: GI score 22, nutritional resilience 68, adherence 87.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02354 | 30% | S01 | CR-01 | improved | 78 |
| P-02698 | 34% | S06 | ME-01 | improved | 71 |
| P-02553 | 34% | S13 | — | — | 71 |
| P-02550 | 31% | S01 | — | — | 70 |
| P-02192 | 32% | S05 | — | — | 69 |
| P-02214 | 32% | S08 | SC-12 | no change | 69 |
| P-02083 | 30% | S13 | — | — | 69 |
| P-02293 | 33% | S15 | HY-01 | no change | 68 |
| P-02090 | 36% | S04 | — | — | 68 |
| P-02518 | 32% | S17 | DT-01 | improved | 68 |
| P-02604 | 31% | S03 | — | — | 67 |
| P-02194 | 31% | S03 | — | — | 67 |